Probiotics and prebiotics: potential prevention and therapeutic target for nutritional management of COVID-19?

KS Batista, JG de Albuquerque… - Nutrition research …, 2023 - cambridge.org
Scientists are working to identify prevention/treatment methods and clinical outcomes of
coronavirus disease 2019 (COVID-19). Nutritional status and diet have a major impact on …

Screening S protein–ACE2 blockers from natural products: strategies and advances in the discovery of potential inhibitors of COVID-19

H Liu, X Liu, X Yuan, C Xu, F Wang, J Lin, R Xu… - European Journal of …, 2021 - Elsevier
Abstract The Coronavirus disease, 2019 (COVID-19) is caused by severe acute respiratory
syndrome Coronavirus 2 (SARS-CoV-2), which poses a major threat to human life and …

Identification of cyanobacteria-based natural inhibitors against SARS-CoV-2 druggable target ACE2 using molecular docking study, ADME and toxicity analysis

N Sahu, S Mishra, M Kesheri, S Kanchan… - Indian Journal of Clinical …, 2023 - Springer
Abstract In 2019–2020, the novel “severe acute respiratory syndrome coronavirus-2 (SARS-
CoV-2)” had emerged as the biggest challenge for humanity, causing “coronavirus disease …

SARS-CoV-2: Pathogenesis, molecular targets and experimental models

G Kanimozhi, B Pradhapsingh… - Frontiers in …, 2021 - frontiersin.org
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a recent pandemic
outbreak threatening human beings worldwide. This novel coronavirus disease-19 (COVID …

Urtica dioica agglutinin (UDA) as a potential candidate for inhibition of SARS-CoV-2 Omicron variants: In silico prediction and experimental validation

F Sabzian-Molaei, S Hosseini, A Alipour, H Ghaderi… - Phytomedicine, 2023 - Elsevier
Background The high number of mutations and consequent structure modifications in a
Receptor-Binding Domain (RBD) of the spike protein of the Omicron variant of SARS-CoV-2 …

First report on chemometrics-driven multilayered lead prioritization in addressing oxysterol-mediated overexpression of G protein-coupled receptor 183

A Bhattacharjee, S Kar, PK Ojha - Molecular Diversity, 2024 - Springer
Contemporary research has convincingly demonstrated that upregulation of G protein-
coupled receptor 183 (GPR183), orchestrated by its endogenous agonist, 7α, 25 …

The medicinal chemistry of Urtica dioica L.: from preliminary evidence to clinical studies supporting its neuroprotective activity

P Semwal, A Rauf, A Olatunde, P Singh… - Natural products and …, 2023 - Springer
Urtica dioica is a perennial herb from the family of Urticaceae that is commonly known as
stinging nettle. This plant is widespread in Europe, Africa, America, and a part of Asia, as it …

The potential roles of ficus carica extract in the management of COVID-19 viral infections: A computer-aided drug design study

M Hamed, M Khalifa, MA El Hassab… - … -Aided Drug Design, 2024 - ingentaconnect.com
Introduction: The conventional processes of drug discovery are too expensive,
timeconsuming and the success rate is limited. Searching for alternatives that have evident …

Jeopardy of COVID-19: rechecking the perks of phytotherapeutic interventions

P Saha, S Bose, AK Srivastava, AA Chaudhary, R Lall… - Molecules, 2021 - mdpi.com
The novel coronavirus disease (COVID-19), the reason for worldwide pandemic, has
already masked around 220 countries globally. This disease is induced by Severe Acute …

Gene expression and anticancer evaluation of Kigelia africana (Lam.) Benth. Extracts using MDA-MB-231 and MCF-7 cell lines

A Kalsoom, A Altaf, H Sattar, T Maqbool, M Sajjad… - Plos one, 2024 - journals.plos.org
In recent years, a cancer research trend has shifted towards identifying novel therapeutic
compounds from natural assets for the management of cancer. In this study, we aimed to …